Phil Quirke
Phil Quirke
Verified email at
Cited by
Cited by
Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial
PJ Guillou, P Quirke, H Thorpe, J Walker, DG Jayne, AMH Smith, ...
The lancet 365 (9472), 1718-1726, 2005
Local recurrence of rectal adenocarcinoma due to inadequate surgical resection: histopathological study of lateral tumour spread and surgical excision
P Quirke, MF Dixon, P Durdey, NS Williams
The Lancet 328 (8514), 996-999, 1986
Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group
DG Jayne, PJ Guillou, H Thorpe, P Quirke, J Copeland, AMH Smith, ...
Journal of Clinical Oncology 25 (21), 3061-3068, 2007
Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial
D Sebag-Montefiore, RJ Stephens, R Steele, J Monson, R Grieve, ...
The Lancet 373 (9666), 811-820, 2009
Role of circumferential margin involvement in the local recurrence of rectal cancer
IJ Adam, IG Martin, PJ Finan, D Johnston, MO Mohamdee, N Scott, ...
The Lancet 344 (8924), 707-711, 1994
Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer
DG Jayne, HC Thorpe, J Copeland, P Quirke, JM Brown, PJ Guillou
Journal of British Surgery 97 (11), 1638-1645, 2010
What is the role for the circumferential margin in the modern treatment of rectal cancer?
ID Nagtegaal, P Quirke
Journal of Clinical Oncology 26 (2), 303-312, 2008
Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’study
HJN Andreyev, AR Norman, D Cunningham, J Oates, BR Dix, ...
British journal of cancer 85 (5), 692-696, 2001
Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 …
P Quirke, R Steele, J Monson, R Grieve, S Khanna, J Couture, ...
The Lancet 373 (9666), 821-828, 2009
Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control.
ID Nagtegaal, CJH van de Veld, E Worp, E Kapiteijn, P Quirke, ...
Complete mesocolic excision with central vascular ligation produces an oncologically superior specimen compared with standard surgery for carcinoma of the colon
NP West, W Hohenberger, K Weber, A Perrakis, PJ Finan, P Quirke
Journal of clinical oncology 28 (2), 272-278, 2010
Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery
KF Birbeck, CP Macklin, NJ Tiffin, W Parsons, MF Dixon, NP Mapstone, ...
Annals of surgery 235 (4), 449, 2002
Effect of robotic-assisted vs conventional laparoscopic surgery on risk of conversion to open laparotomy among patients undergoing resection for rectal cancer: the ROLARR …
D Jayne, A Pigazzi, H Marshall, J Croft, N Corrigan, J Copeland, P Quirke, ...
Jama 318 (16), 1569-1580, 2017
Low rectal cancer: a call for a change of approach in abdominoperineal resection.
ID Nagtegaal, CJ Van de Velde, CA Marijnen, JHJM van Krieken, ...
Long-term follow-up of the Medical Research Council CLASICC trial of conventional versus laparoscopically assisted resection in colorectal cancer
BL Green, HC Marshall, F Collinson, P Quirke, P Guillou, DG Jayne, ...
Journal of British Surgery 100 (1), 75-82, 2013
Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer
G Hutchins, K Southward, K Handley, L Magill, C Beaumont, ...
J Clin Oncol 29 (10), 1261-1270, 2011
WISP genes are members of the connective tissue growth factor family that are up-regulated in Wnt-1-transformed cells and aberrantly expressed in human colon …
D Pennica, TA Swanson, JW Welsh, MA Roy, DA Lawrence, J Lee, ...
Proceedings of the National Academy of Sciences 95 (25), 14717-14722, 1998
KRAS and BRAF Mutations in Advanced Colorectal Cancer Are Associated With Poor Prognosis but Do Not Preclude Benefit From Oxaliplatin or Irinotecan …
SD Richman, MT Seymour, P Chambers, F Elliott, CL Daly, AM Meade, ...
Journal of Clinical Oncology 27 (35), 5931-5937, 2009
Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter …
FGM Taylor, P Quirke, RJ Heald, B Moran, L Blomqvist, I Swift, ...
Annals of surgery 253 (4), 711-719, 2011
Magnetic resonance imaging–detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience
UB Patel, F Taylor, L Blomqvist, C George, H Evans, P Tekkis, P Quirke, ...
Journal of Clinical Oncology 29 (28), 3753-3760, 2011
The system can't perform the operation now. Try again later.
Articles 1–20